Multimodal data fusion: integrating PET/MRI and liquid biopsy for a holistic view of cancer biology

1

The integration of PET/MRI imaging with liquid biopsy enhances understanding of tumor biology by combining spatial and molecular data.
2

This multimodal approach improves clinical decision-making, facilitating early diagnosis, treatment monitoring, and tracking drug resistance.
3

Current evidence supports the potential of this synergy, although challenges in standardization and data integration remain.
4

PET/MRI provides high-resolution anatomical and functional imaging, while liquid biopsy offers real-time molecular insights.
5

Advancements in artificial intelligence are crucial for overcoming integration challenges and advancing precision oncology.

1